Key points are not available for this paper at this time.
Real-life data confirm nabiximols as an effective and well-tolerated treatment option for resistant MSS in clinical practice.
Flachenecker et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: